Concepedia

Publication | Open Access

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

58

Citations

17

References

2020

Year

References

YearCitations

Page 1